For research use only. Not for therapeutic Use.
LY-338979（Cat No.:R056014）is an investigational small molecule being developed for the treatment of neurological disorders, particularly those related to pain and neurodegenerative diseases. It is designed to target specific receptors and signaling pathways involved in pain transmission and neuroinflammation. LY-338979 has shown potential in preclinical studies for reducing chronic pain and protecting against neuronal damage. By modulating the neuroimmune system and offering neuroprotective effects, it may be an effective alternative to traditional painkillers and treatments for conditions such as Alzheimer’s and Parkinson’s disease. Clinical trials are underway to assess its safety and efficacy.
| CAS Number | 193281-00-4 |
| Synonyms | (2S)-2-[[4-[2-(2-amino-4,6-dioxo-5,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid |
| Molecular Formula | C20H21N5O7 |
| Purity | ≥95% |
| IUPAC Name | (2S)-2-[[4-[2-(2-amino-4,6-dioxo-5,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid |
| InChI | InChI=1S/C20H21N5O7/c21-20-24-15-14(18(30)25-20)11(17(29)23-15)6-3-9-1-4-10(5-2-9)16(28)22-12(19(31)32)7-8-13(26)27/h1-2,4-5,11-12H,3,6-8H2,(H,22,28)(H,26,27)(H,31,32)(H4,21,23,24,25,29,30)/t11?,12-/m0/s1 |
| InChIKey | YVRHJHKPTURIID-KIYNQFGBSA-N |
| SMILES | C1=CC(=CC=C1CCC2C3=C(NC2=O)N=C(NC3=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O |
